BOSTON & CAMBRIDGE, England, February 06, 2025--(BUSINESS WIRE)--Broken String Biosciences ("Broken String"), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program ...

CAMBRIDGE, England, November 17, 2025--(BUSINESS WIRE)--Broken String Biosciences ("Broken String"), a leader in advancing gene editing safety, today announced the appointment of new leadership to ...

Resulting technology, called SafeGuide, will enable faster, more cost-effective development of gene edited therapies like CRISPR BOSTON & CHICAGO & CAMBRIDGE, England, July 10, 2025--(BUSINESS ...

Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program (EAP) for developers of gene-edited therapies that allow for the ...

Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization Broken String Biosciences (“Broken String”), ...

The MarketWatch News Department was not involved in the creation of this content. -- Eurostar grant supports application of BioLizard's AI expertise to Broken String's INDUCE-seq(R) platform -- ...

Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today announced the appointment of new leadership to drive the commercialization of its INDUCE-seq ® platform, ...